Dialysis Access Drops in a Stepwise Pattern as Neighborhood Disadvantage Rises

End-stage kidney disease is one of the most demanding chronic conditions a patient can face. Three times a week, for three to five hours per session, patients on hemodialysis must travel to a dialysis facility where their blood is filtered by machine -- a process their kidneys can no longer perform adequately on their own. Missing or shortening treatments carries direct health consequences: fluid accumulation, electrolyte imbalances, and over time, increased mortality. Getting to the clinic is not optional.

For patients in communities with limited resources, that required travel is considerably harder to manage. A study published in JAMA Internal Medicine quantifies the relationship between community disadvantage and dialysis facility access at a national scale, finding a consistent, stepwise pattern: the more disadvantaged a community, the fewer dialysis facilities are within reasonable reach.

Measuring Disadvantage and Access

The researchers used established indices of community socioeconomic disadvantage -- measures combining information on poverty rates, educational attainment, housing quality, unemployment, and related indicators -- to characterize the conditions in which patients with end-stage kidney disease live. They then measured facility access through distance and travel time to the nearest dialysis center, controlling for population density to ensure that rural-urban differences did not confound the disadvantage measure.

The finding was that as disadvantage increased across quintiles of the deprivation index, access to dialysis decreased in a consistent, stepwise manner. This was not a threshold effect confined to only the most disadvantaged communities. Instead, the gradient was continuous: each step toward greater disadvantage corresponded to a step toward lower access, across the full distribution of community conditions.

Why Dialysis Access Follows Wealth

The geographic distribution of dialysis facilities is shaped by multiple forces that tend to concentrate services in areas of greater economic activity and insurance coverage. Facility operators make location decisions based on patient volume projections and reimbursement expectations. Areas with higher concentrations of insured patients, better transportation infrastructure, and more stable commercial real estate markets are more attractive for new facility development.

Low-income communities may have sufficient numbers of end-stage kidney disease patients -- indeed, disadvantaged communities have higher rates of the conditions that lead to kidney failure, including diabetes and hypertension -- but the combination of insurance status, payment mix, and operational costs may make them less attractive for facility investment. The result is an access gap that falls most heavily on the patients who already face the greatest disease burden.

The Clinical Consequences of Distance

The health consequences of poor dialysis access are not merely inconveniences. Patients who miss dialysis treatments due to transportation barriers have higher rates of fluid overload, hyperkalemia, and uremic complications. Hospitalizations related to missed or shortened dialysis are common and costly. Mortality risk increases with treatment adherence problems, and transportation difficulty is a documented contributor to non-adherence in dialysis populations.

Research on dialysis transportation assistance programs has found meaningful improvements in adherence and reduced hospitalization when such programs are available. The JAMA Internal Medicine findings suggest that transportation assistance, while valuable, does not fully solve the access problem when facilities are simply not located within manageable distance of disadvantaged communities.

Policy Responses

The study's findings point toward several possible responses. Incentive programs to encourage facility development in underserved areas could shift the economics of facility location. Home dialysis -- particularly peritoneal dialysis performed by patients at home without travel -- addresses the access problem structurally rather than by moving facilities. The U.S. home dialysis rate remains below 15%, far lower than in many comparable countries. For patients in the most disadvantaged and facility-scarce communities, home dialysis represents an alternative that could reduce the survival gap associated with poor geographic access. The stepwise relationship between community disadvantage and dialysis access documented in this study reflects structural features of the health care market that are unlikely to self-correct without deliberate policy intervention.